patients with: glaucoma ocular hypertension
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patient 1) Male or female older than 20 years-old 2) patients with glaucoma or ocular hypertension 3) Subjects who sign an informed consent form to participate in the clinical study
Exclusion criteria
Exclusion criteria: 1) Having any side-effects (hypersensitivity, rised intraocular pressure etc.) against mydriatics 2) Revealed narrow angle by slit-lamp examination 3) When a doctor accepted the middle-class above-mentioned cataract 4) Subjects who a doctor in attendance declares ineligible for any reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood flow rate in macular capillaries before and at 7days, 1 and 3months after starting topical anti-glaucoma medications | — |
Secondary
| Measure | Time frame |
|---|---|
| Diameter of macular capillaries before and at 7days, 1 and 3months after starting topical anti-glaucoma medications | — |
Countries
Japan
Contacts
Kyoto University Graduate School of Medicine Ophthalmology & Visual Sciences